Small interfering RNA targeting bcl-2 sensitizes malignant melanoma. Wacheck V, Losert D, Günsberg P, Vornlocher HP, Hadwiger P, Geick A, Pehamberger H, Müller M, Jansen B.Oligonucleotides. 2003;13(5):393-400. View Abstract on PubMed
The apparent uptake of fluorescently labeled siRNAs by electroporated cells depends on the fluorochrome. Dunne J, Drescher B, Riehle H, Hadwiger P, Young BD, Krauter J, Heidenreich O. Oligonucleotides. 2003;13(5):375-80. View Abstract on PubMed
Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). Wohlbold L, van der Kuip H, Miething C, Vornlocher HP, Knabbe C, Duyster J, Aulitzky WE. Blood. 2003 Sep 15;102(6):2236-9. Epub 2003 May 15. View Abstract on PubMed
Gene silencing by RNAi in mammalian cells. John M, Geick A, Hadwiger P, Vornlocher HP, Heidenreich O. Curr Protoc Mol Biol. 2003 May;Chapter 26:Unit 26.2. View Abstract on PubMed
A new class of Spiegelmers containing 2'-fluoro-nucleotides. Helmling S, Moyroud E, Schroeder W, Roehl I, Kleinjung F, Stark S, Bahrenberg G, Gillen C, Klussmann S, Vonhoff S.Nucleosides Nucleotides Nucleic Acids. 2003 May-Aug;22(5-8):1035-8. View Abstract on PubMed
Aminomodified nucleobases: functionalized nucleoside triphosphates applicable for SELEX. Schoetzau T, Langner J, Moyroud E, Roehl I, Vonhoff S, Klussmann S. Bioconjug Chem.2003 Sep-Oct;14(5):919-26. View Abstract on PubMed
AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells. Heidenreich O, Krauter J, Riehle H, Hadwiger P, John M, Heil G, Vornlocher HP, Nordheim A. Blood. 2003 Apr 15;101(8):3157-63. Epub 2002 Dec 12. View Abstract on PubMed
siRNA als Plattform für die Entwicklung innovativer Therapeutika in der Onkologie.Wacheck V und Vornlocher HP. Der Onkologe. 2003; 9:1121-1129. View Abstract
Gene silencing by RNAi in mammalian cells. John M, Geick A, Hadwiger P, Vornlocher HP, Heidenreich O. In: Current Protocols in Molecular Biology, John Wiley & Sons, New York.(2003) pp. 26.2.1-26.2.14. View Abstract on PubMed